View Older Stories View More Recent Stories
-
Minerva Neurosciences Announces Financing of up to $200 Million to Advance Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia Through a Phase 3 Confirmatory Trial and R
-
Lexeo Therapeutics closes $153.8 million public offering and private placement
-
Lexeo Therapeutics Announces Closing of Public Offering and Concurrent Private Placement and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares in the Public Offering
-
Lexeo Therapeutics prices $135 million public offering at $8 per share
-
Lexeo Therapeutics Announces Pricing of Public Offering and Concurrent Private Placement
-
Lexeo Therapeutics launches stock offering and private placement
-
Lexeo Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants
-
Factbox-How hedge funds performed in September
-
Ovid Therapeutics raises up to $175 million in private placement
-
Ovid Therapeutics Announces Pricing of Private Placement Totaling up to $175 Million in Gross Proceeds
-
Howard Cheng Joins Carrick Lane as Partner and Head of Risk
-
CAMP4 raises up to $100 million for SYNGAP1 disorder treatment
-
CAMP4 raises up to $100 million for SYNGAP1 disorder treatment
-
CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders
-
ADFW 2025: World's Financial Elite Managing Over USD 60 Trillion to Explore How Technology is Shaping Finance
-
iBio closes $50 million public offering led by Balyasny
-
iBio Announces Closing of $50 Million Public Offering
-
Form SCHEDULE 13G/A Shapeways Holdings, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form SCHEDULE 13G Lexeo Therapeutics, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form SCHEDULE 13G/A Beyond Air, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form SCHEDULE 13G/A Verastem, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form SCHEDULE 13G Camping World Holdings, Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form SCHEDULE 13G Spirit AeroSystems Holdi Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Silicon Valley Defense Group Names Virtualitics to NatSec100 List for Mission-Critical AI Innovation
-
F.N.B. Corp's (FNB) First National Bank names Chris Chan as CSO
-
FNB Appoints Christopher Chan as Chief Strategy Officer
-
Form SCHEDULE 13G/A Verastem, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form SCHEDULE 13G/A Beyond Air, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form SCHEDULE 13G/A Shapeways Holdings, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form SCHEDULE 13G/A Hudson Pacific Propertie Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Centri Announces Final Schedule for Capital Conference at Nasdaq on April 22
-
March hedge fund stock selloff buoys some, costs others, sources say
-
StandardAero (SARO) appoints Rama Bondada as VP of Investor Relations
-
StandardAero Appoints Rama Bondada to Vice President, Investor Relations
-
Senti Biosciences (SNTI) Strengthens Leadership Team with Strategic Hires
-
Senti Bio Strengthens Leadership Team with Strategic Hires
-
Form SCHEDULE 13G Verastem, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form SCHEDULE 13G/A LEAP THERAPEUTICS, INC. Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form SCHEDULE 13G Hudson Pacific Propertie Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form SCHEDULE 13G Beyond Air, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form SCHEDULE 13G/A Shapeways Holdings, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Five9 (FIVN) Appoints Sagar Gupta to Board of Directors
-
Five9 Appoints Sagar Gupta to Board of Directors, with Backing from Anson Funds and Scalar Gauge Fund
-
Form SC 13G/A Shapeways Holdings, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form SC 13G LEAP THERAPEUTICS, INC. Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form SC 13G/A Pyrophyte Acquisition Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form SC 13G/A WW INTERNATIONAL, INC. Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form SC 13G/A Lottery.com Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form SC 13G/A Mersana Therapeutics, Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
CoinShares Appoints Lisa Avellini as Group General Counsel

